Women's Reproductive Health Research

女性生殖健康研究

基本信息

  • 批准号:
    10063806
  • 负责人:
  • 金额:
    $ 29.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-09-30 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT The core academic mission of the Department of Obstetrics, Gynecology and Reproductive Sciences (Ob, Gyn & RS) at the University of California, San Francisco (UCSF) is to promote health and prevent disease in women by developing a well-trained, productive, and diverse cohort of clinician investigators who conduct high impact research. The UCSF WRHR program has been funded since 1998 to recruit outstanding Scholars and provide them with the critical skills and training needed to succeed as independent investigators. Fourteen superb WRHR Scholars have been recruited to the program for mentored career development; 12 have completed the WRHR training and 2 are current scholars. Our WRHR alumni have made major contributions to science including basic and translational discoveries in reproductive health and breakthroughs in clinical research across the broad range of disciplines within Obstetrics and Gynecology. Over the next 5 years, we propose to continue supporting our existing 2 Scholars who have made excellent progress in completing their specific aims, and then will recruit 2 new outstanding Scholars to provide a mentored career development experience. We will build upon our recent successes in improving diversity of the applicant pool and focus our efforts on increasing the number of Scholars from under-presented racial or ethnic minority groups (UIM). We will also focus on new opportunities for Scholars to learn research methods of emerging, cutting-edge scientific fields. To this end, Scholars will be recruited to pursue biomedical (laboratory-based), translational, and/or and clinical research in reproductive science. Two research pathways have been established to guide relatively inexperienced (Track I) and more experienced Scholars (Track II). The Program Aims of the UCSF WRHR are: 1) To recruit and retain a cohort of outstanding, diverse, well-trained women's health research Scholars who aim to advance scientific discoveries in basic, clinical, and translational reproductive sciences 2) To provide Scholars with an individualized plan that provides the necessary didactic training, guided mentorship, and research resources and environment required to successfully create an independent research career in women's health 3) To improve the diversity of women's health research faculty by implementing programs and strategies to attract faculty that are under-represented in medicine (UIM) and provide critical support and resources for UIM Scholars to launch and sustain a research career. 4) To advance women's health and support Scholars by creating and sustaining strong collaborations and programmatic links with institutional partners focused on training and mentoring junior research faculty. At UCSF, we have a robust, thriving, research environment and strong institutional support for career development, coupled with an active and diverse research enterprise within the Department of Ob, Gyn, & RS. These resources and environment enable our WRHR program to thrive and succeed in developing the next generation of independent investigators that advance women's health and wellness.
摘要 妇产科与生殖科学系(Ob,Gyn)的核心学术使命 加州大学旧金山分校弗朗西斯科(UCSF)的一项研究旨在促进女性健康和预防疾病 通过培养一批训练有素、富有成效和多样化的临床研究人员, research. UCSF WRHR计划自1998年以来一直获得资助,以招募优秀学者并提供 他们具备作为独立调查员取得成功所需的关键技能和培训。十四个一流的WRHR 学者已被招募到该计划的指导职业发展; 12个已经完成了WRHR 培训人员和2名现任学者。我们的WRHR校友对科学做出了重大贡献,包括基础 生殖健康领域的重大发现和临床研究的突破 妇产科的一系列学科。在未来5年,我们将继续支持 我们现有的2名学者谁取得了出色的进展,在完成他们的具体目标,然后将招募 2名新的杰出学者提供指导的职业发展经验。我们将在最近的基础上 成功地提高了申请人的多样性,并集中精力增加学者的数量 少数民族或少数族裔群体(UIM)。我们还将关注学者的新机会 学习新兴前沿科学领域的研究方法。为此,将招募学者, 从事生殖科学的生物医学(实验室),转化和/或临床研究。两 已经建立了研究途径,以指导相对缺乏经验的(轨道I)和更有经验的 学者(第二轨道)。UCSF WRHR的计划目标是:1)招募和留住一批优秀的, 多样化,训练有素的妇女健康研究学者谁的目标是推进科学发现的基础, 临床和转化生殖科学2)为学者提供个性化的计划, 必要的教学培训,指导导师,研究资源和环境, 成功地在妇女健康方面开创了独立的研究事业3)为了提高妇女健康的多样性, 健康研究教师通过实施计划和战略,以吸引教师是代表性不足, 医学(UIM),并为UIM学者提供关键的支持和资源,以启动和维持研究 事业4)通过建立和维持强有力的合作,促进妇女的健康并支持学者 与机构伙伴建立方案联系,重点是培训和指导初级研究人员。在 加州大学旧金山分校,我们有一个强大的,蓬勃发展的,研究环境和强大的机构支持的职业生涯 发展,再加上一个积极和多样化的研究企业在妇产科, & RS。这些资源和环境使我们的WRHR计划能够蓬勃发展,并成功地发展 下一代独立调查人员,促进妇女的健康和福祉。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AMY P. MURTHA其他文献

AMY P. MURTHA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AMY P. MURTHA', 18)}}的其他基金

MATERNAL SERUM INTERLEUKIN-6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
  • 批准号:
    7198448
  • 财政年份:
    2005
  • 资助金额:
    $ 29.22万
  • 项目类别:
Maternal Serum IL6 in Preterm Premature Rupture of Mem.
早产儿子宫肌层过早破裂的母体血清 IL6。
  • 批准号:
    6974007
  • 财政年份:
    2004
  • 资助金额:
    $ 29.22万
  • 项目类别:
MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
  • 批准号:
    6565361
  • 财政年份:
    2001
  • 资助金额:
    $ 29.22万
  • 项目类别:
MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
  • 批准号:
    6415302
  • 财政年份:
    2000
  • 资助金额:
    $ 29.22万
  • 项目类别:
MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
  • 批准号:
    6463064
  • 财政年份:
    2000
  • 资助金额:
    $ 29.22万
  • 项目类别:
MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
  • 批准号:
    6503101
  • 财政年份:
    2000
  • 资助金额:
    $ 29.22万
  • 项目类别:
MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
  • 批准号:
    6112785
  • 财政年份:
    1998
  • 资助金额:
    $ 29.22万
  • 项目类别:
MATERNAL SERUM INTERLEUKIN 6 IN PRETERM PREMATURE RUPTURE OF MEMBRANES
早产儿胎膜早破中的母体血清白细胞介素 6
  • 批准号:
    6274019
  • 财政年份:
    1997
  • 资助金额:
    $ 29.22万
  • 项目类别:
EVALUATION OF CORTICOSTEROIDS IN REFRACTORY HYPEREMESIS
难治性剧吐中皮质类固醇的评估
  • 批准号:
    6274007
  • 财政年份:
    1997
  • 资助金额:
    $ 29.22万
  • 项目类别:
EVALUATION OF CORTICOSTEROIDS IN REFRACTORY HYPEREMESIS
难治性剧吐中皮质类固醇的评估
  • 批准号:
    6112773
  • 财政年份:
  • 资助金额:
    $ 29.22万
  • 项目类别:

相似国自然基金

Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.22万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 29.22万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 29.22万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 29.22万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 29.22万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 29.22万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 29.22万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 29.22万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 29.22万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 29.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了